<div><p>A. Absolute CD4+ T cell counts at baseline (n=485 and n=216) and 3 (n=369 and n=180), 6 (n=372 and n=157), 12 (n=283 and n=128), 24 (n=247 and n=113) and 36 (n=241 and n=119) months after start of cART for patients with and without X4-HIV variants. Statistical significance was tested using the nonparametric Mann-Whitney test. Significance is indicated as follows: ** p<0.01 *** p<0.0001.</p> <p>B. Change in CD4+ T cell counts 3, 6, 12, 24 and 36 months after start of therapy compared to baseline CD4+ T cell count at start of treatment for patients with and without X4-HIV variants. Statistical significance was tested using the nonparametric Mann-Whitney test.</p></div
International audienceThe aim of the study was to investigate the impact of first-line combined anti...
International audienceThe aim of the study was to investigate the impact of first-line combined anti...
International audienceThe aim of the study was to investigate the impact of first-line combined anti...
Objective: Treatment guidelines recommend initiation of therapy for individuals experiencing rapid ...
BACKGROUND: Achieving virologic suppression is a clear therapeutic goal for patients receiving combi...
BACKGROUND:: Achieving virologic suppression is a clear therapeutic goal for patients receiving comb...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...
BACKGROUND: CD4+ T-cell recovery in patients with continuous suppression of plasma HIV-1 viral load ...
BACKGROUND: CD4+ T-cell recovery in patients with continuous suppression of plasma HIV-1 viral load ...
BACKGROUND: CD4+ T-cell recovery in patients with continuous suppression of plasma HIV-1 viral load ...
CD4+ T-cell subsets expressing CCR6+CD161+ significantly increased in the peripheral blood following...
Successful combination antiretroviral therapy (cART) increases levels of CD4+ T-cells, however this ...
International audienceThe aim of the study was to investigate the impact of first-line combined anti...
Objective: To examine CD4 cell responses to combination antiretroviral therapy (cART) in patients en...
International audienceThe aim of the study was to investigate the impact of first-line combined anti...
International audienceThe aim of the study was to investigate the impact of first-line combined anti...
International audienceThe aim of the study was to investigate the impact of first-line combined anti...
Objective: Treatment guidelines recommend initiation of therapy for individuals experiencing rapid ...
BACKGROUND: Achieving virologic suppression is a clear therapeutic goal for patients receiving combi...
BACKGROUND:: Achieving virologic suppression is a clear therapeutic goal for patients receiving comb...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...
BACKGROUND: CD4+ T-cell recovery in patients with continuous suppression of plasma HIV-1 viral load ...
BACKGROUND: CD4+ T-cell recovery in patients with continuous suppression of plasma HIV-1 viral load ...
BACKGROUND: CD4+ T-cell recovery in patients with continuous suppression of plasma HIV-1 viral load ...
CD4+ T-cell subsets expressing CCR6+CD161+ significantly increased in the peripheral blood following...
Successful combination antiretroviral therapy (cART) increases levels of CD4+ T-cells, however this ...
International audienceThe aim of the study was to investigate the impact of first-line combined anti...
Objective: To examine CD4 cell responses to combination antiretroviral therapy (cART) in patients en...
International audienceThe aim of the study was to investigate the impact of first-line combined anti...
International audienceThe aim of the study was to investigate the impact of first-line combined anti...
International audienceThe aim of the study was to investigate the impact of first-line combined anti...